XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.3

Net Income (Loss) per Share (Tables)

9 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Schedule of Reconciliation of Weighted Average Shares Outstanding Calculation

The following table provides a reconciliation of the weighted average shares outstanding calculation for the three and nine months ended September 30, 2024 and 2023:

Weighted average number of basic shares outstanding
			Three months ended September 30,												Nine months ended September 30,
			2024						2023						2024						2023
Weighted average shares issued			28,000,886						16,825,286						26,347,229						12,745,035
Weighted average pre-funded warrants			737,421						1,037,792						987,983						1,240,213
Weighted average shares outstanding			28,738,307						17,863,078						27,335,212						13,985,248

Weighted average number of diluted shares outstanding
			Three months ended September 30,												Nine months ended September 30,
			2024						2023						2024						2023
Weighted average shares outstanding (Basic)			28,738,307						17,863,078						27,335,212						13,985,248
Additional dilutive shares			3,607,365						—						—						—
Weighted average shares outstanding (Diluted)			32,345,672						17,863,078						27,335,212						13,985,248

Schedule of Potentially Dilutive Securities Excluded from the Computation of Earnings Per Share

The following potentially dilutive securities were excluded from the computation of earnings per share as of September 30, 2024 and 2023 because their effects would be anti-dilutive:

			Three Months Ended September 30,												Nine Months Ended September 30,
			2024						2023						2024						2023
Common stock warrants			3,610,743						3,627,409						3,627,409						3,627,409
Assumed conversion of preferred stock warrants			—						4,149,994						4,108,328						4,149,994
Assumed conversion of preferred stock			—						7,417,473						1,454,509						7,417,473
Assumed conversion of convertible notes			237,614						488,031						237,614						488,031
Stock options			1,489,310						4,136,828						6,055,728						4,136,828
Total			5,337,667						19,819,735						15,483,588						19,819,735

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration